Key result
Indomethacin impairs the antihypertensive effect of atenolol, whereas sulindac shows no interaction.
RCT
Randomised crossover
Answers are grounded in this paper and cite their sources.
Indomethacin and sulindac were used as tools to study the role of renal and/or systemic prostaglandins in the pharmacological response to atenolol. Patients receiving chronic treatment with atenolol 100 mg received indomethacin 50 mg twice daily or sulindac 200 mg twice daily in a randomised crossover trial. Indomethacin significantly reduced the antihypertensive action of atenolol while sulindac had no effect. The role that systemic and/or renal prostaglandins may play in the antihypertensive action of atenolol is discussed with reference to renal PGI2 production and inhibition of platelet cyclo-oxygenase.
No takes yet. Share an insight, caveat, or question.
Salvetti et al. (1984) conducted an RCT in Hypertension. Indomethacin vs. Sulindac 200 mg twice daily was evaluated on Antihypertensive action of atenolol. Indomethacin reduced the antihypertensive action of atenolol, whereas sulindac had no effect.
Synapse has enriched 10 related papers. Consider them for comparative context: